New stroke drug shows promise in Mid-Stage trial
Disease control
Recruiting now
This study tests an experimental drug called QHRD106 for people who have had an acute ischemic stroke. The goal is to see if it helps improve recovery and reduce disability. About 320 adults aged 18 to 80 who have not received standard clot-busting treatment will receive either t…
Phase: PHASE2 • Sponsor: Changzhou Qianhong Bio-pharma Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC